Latest Breaking News On - Nasdaq news cerevel therapeutics holdings inc abbvie - Page 1 : comparemela.com

AbbVie has signed a definitive agreement to acquire Cerevel Therapeutics and its neuroscience pipeline – including antipsychotic emraclidine – for approximately $8.7 billion. Cerevel s pipeline.

United kingdomUnited statesEurope america asiaDeutsch schweizDeutsch deutschlandNederlands nederlandAboutsurperformance sasaboutMt piper sandlerNederlands belgiRicharda gonzalezCerevel therapeutics holdings incHealth care decAbbvie incRe health flat as obesityNasdaq news cerevel therapeutics holdings inc abbvieCompany profile cerevel therapeutics holdings inc